Tumorigencity decrease in Bcl-xL deficient MDCK cells ensuring the safety for influenza vaccine production
Jiahao Zheng, Boran Li, Lanxin Jia, Jiayou Zhang, Zheng Gong, Le Yang, Xuanxuan Nian, Xuedan Li, Bo Liu, Daiguan Yu, Zhegang Zhang, Changgui Li
The paper knocks out Bcl-xL in MDCK cells to reduce tumorigenicity, creating a safer cell line for influenza vaccine production.
PLoS ONE · Dec 16, 2024Peer-reviewedCell Biology